This article is more than 5 years old. Information may no longer be current.

Non-sterile metronidazole USP injections recalled

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Sagent Pharmaceuticals issued a nationwide voluntary recall Monday of all lots of metronidazole injection, USP 500 mg/100 mL, because of non-sterile products discovered in two lots, according to a press release.

USP is an IV antimicrobial used to treat infections and is supplied in a single-dose plastic container. Non-sterility of an antimicrobial administered via IV has the potential to result in potentially fatal infections, particularly among patients who are immunocompromised, the FDA said in a MedWatch safety statement.

Recalled lot numbers were distributed to hospitals, wholesalers and distributors from February through May and include: A090742, A090743, A090744, A090745, A090746, A090769, A090770, A090771, A090772, A090773, A090774, A090775, A090776, A090968, A091014, A000013, A000016 and A000019.

Sagent is not aware of any adverse events related to the recalled product thus far and will continue to investigate, according to the FDA.